217. Antimicrobial Activity of Dalbavancin against Gram-Positive Bacteria Isolated from Patients Hospitalized with Bacteremia in United States and European Medical Centers: Results from the International Dalbavancin Evaluation of Activity (IDEA) Program (2018-202)

BACKGROUND: The IDEA Program monitors the in vitro activity of dalbavancin and comparators against Gram-positive (GP) bacteria causing bloodstream infections (BSIs) and other infections in the United States (US) and Europe (EU). We evaluated the BSI results in 2018-2020. METHODS: 8,643 organisms wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Castanheira, Mariana, Huband, Michael D, Shortridge, Dee, Carvalhaes, Cecilia G, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644217/
http://dx.doi.org/10.1093/ofid/ofab466.419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644217/
http://dx.doi.org/10.1093/ofid/ofab466.419

Ejemplares similares